The two most-requested recovery peptides, together, in a needle-free nasal route.
This nasal combination is studied for its potential synergistic activity across complementary tissue biology pathways. TB-500's modulation of actin polymerization may support cell motility and structural repair processes, while BPC-157's engagement of VEGF and nitric oxide signaling pathways is associated with angiogenic activity and connective tissue homeostasis. Research suggests nasal delivery may provide a non-injectable route for systemic peptide distribution. Intended for research purposes.
Shop now ← Back to shop
This spray pairs TB-500 and BPC-157 in one daily-use nasal formula. Delivered intranasally, both peptides bypass first-pass digestive breakdown and reach circulation more directly than an oral capsule would allow. TB-500 is studied for its role in cellular migration and tissue signaling, while BPC-157 is studied for tissue maintenance and structural resilience — two mechanisms researchers view as complementary for recovery-focused protocols.
Research Use Only. These products have not been evaluated or approved by the FDA for use as drugs, therapeutics, diagnostics, or dietary supplements, and are not intended for administration to humans or animals. No product description or mechanism-of-action information constitutes a health claim or therapeutic endorsement. Any clinical use is at the sole discretion of a licensed healthcare provider in compliance with applicable laws. Individual results may vary.